HIGHLIGHTS
- who: Man Yao and colleagues from the Department of Integrative Oncology, The First Affiliated Hospital of Navy Military Medical University, Shanghai, China have published the Article: Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity- Score Matching Analysis, in the Journal: Applied Bionics and Biomechanics of 23/06/2022
- what: This study is aimed at comparing the efficacy and safety profiles of transarterial infusion of recombinant human type-5 adenovirus (H101TACE) with conventional transarterial chemoembolization (cTACE) in patients with unresectable hepatocellular carcinoma (HCC). This study demonstrated that the H101TACE is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.